#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	3114	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2513	367.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1682	1682	C	467	C	383	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5158	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4057	381.0	0	.	n	.	0	T695C	SNP	695	695	T	1264	1264	C	376	C,A	314,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5158	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4057	381.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1906	1906	A	440	A	380	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5158	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4057	381.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2540	2540	C	483	C,A,T	399,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5158	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4057	381.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3166	3166	T	425	T,C	355,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5158	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4057	381.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2614	2614	A	509	A,C	426,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	566	folP	852	852	100.0	folP.l6.c4.ctg.1	1978	85.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1281	1283	AGC	118;118;119	A;G;C	98;103;103	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1150	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3714	92.8	1	SNP	p	S91F	0	.	.	271	273	TCC	705	707	TCC	91;92;91	T;C;C	76;77;78	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1150	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3714	92.8	1	SNP	p	D95N	0	.	.	283	285	GAC	717	719	GAC	91;91;91	G;A;C	76;77;77	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1150	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3714	92.8	1	SNP	p	D95G	0	.	.	283	285	GAC	717	719	GAC	91;91;91	G;A;C	76;77;77	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	432	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1741	74.3	0	.	p	.	0	A39T	NONSYN	115	117	GCC	692	694	ACC	117;117;117	A;C;C,A	102;104;100,1	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	432	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1741	74.3	0	.	p	.	0	R44H	NONSYN	130	132	CGC	707	709	CAC	119;119;120	C;A;C	98;103;105	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	432	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1741	74.3	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	890	892	CAC	121;121;121	C;A;C	107;104;107	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	432	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1741	74.3	1	SNP	p	G45D	0	.	.	133	135	GGC	710	712	GGC	120;121;120	G;G;C	103;103;106	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	304	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1423	64.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1078	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3495	92.6	1	SNP	p	D86N	0	.	.	256	258	GAC	827	829	GAC	101;100;100	G;A;C	88;86;88	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1078	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3495	92.6	1	SNP	p	S87R	0	.	.	259	261	AGT	830	832	AGT	101;104;104	A;G,C,T;T	85;85,1,1;84	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1078	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3495	92.6	1	SNP	p	S87I	0	.	.	259	261	AGT	830	832	AGT	101;104;104	A;G,C,T;T	85;85,1,1;84	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1078	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3495	92.6	1	SNP	p	S87W	0	.	.	259	261	AGT	830	832	AGT	101;104;104	A;G,C,T;T	85;85,1,1;84	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1078	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3495	92.6	1	SNP	p	S88P	0	.	.	262	264	TCC	833	835	TCC	104;104;102	T;C;C	86;86;87	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	888	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3071	86.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1795	1797	GGC	98;98;97	G;G;C,A	80;78;79,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	82.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1450	1452	GCA	92;92;92	G,C;C;A	78,1;77;77	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	82.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1453	1455	ATC	91;91;91	A;T;C	79;78;79	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	82.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1465	1467	GTG	92;92;92	G;T;G	79;81;78	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	82.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1465	1467	GTG	92;92;92	G;T;G	79;81;78	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	82.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1969	1971	ACC	98;98;98	A;C;C	85;86;87	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	82.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2023	2025	GCG	108;108;108	G;C,G;G,C	86;82,1;80,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	82.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2023	2025	GCG	108;108;108	G;C,G;G,C	86;82,1;80,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	82.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2146	2148	GGC	93;93;93	G;G;C	81;79;82	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	82.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2155	2157	GGC	93;93;93	G;G;C,G	77;78;79,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	82.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2173	2175	CCG	93;94;94	C;C,A;G	74;82,1;76	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1172	ponA	2397	2397	99.96	ponA.l6.c17.ctg.1	3510	100.2	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1862	1864	CTG	123;123;123	C,A,T;T;G,T	102,1,1;101;100,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	542	porA	1146	1146	99.83	porA.l6.c4.ctg.1	2189	74.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	766	766	C	84	C	73	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	606	porB1b	1035	1035	96.1	porB1b.l15.c4.ctg.1	1824	97.4	0	.	p	.	0	E48G	NONSYN	142	144	GAA	667	669	GGA	127;127;127	G;G;A	111;108;114	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	606	porB1b	1035	1035	96.1	porB1b.l15.c4.ctg.1	1824	97.4	0	.	p	.	0	F135L	NONSYN	403	405	TTT	928	930	CTT	111;111;111	C;T;T	98;95;98	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	606	porB1b	1035	1035	96.1	porB1b.l15.c4.ctg.1	1824	97.4	0	.	p	.	0	R143G	NONSYN	427	429	AGA	952	954	GGA	113;113;113	G;G;A,C	99;98;98,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	606	porB1b	1035	1035	96.1	porB1b.l15.c4.ctg.1	1824	97.4	0	.	p	.	0	D171G	NONSYN	511	513	GAT	1036	1038	GGT	112;112;112	G;G;T	96;93;96	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	606	porB1b	1035	1035	96.1	porB1b.l15.c4.ctg.1	1824	97.4	0	.	p	.	0	G189S	NONSYN	565	567	GGC	1090	1092	AGC	120;121;121	A,C;G;C	91,1;97;96	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	606	porB1b	1035	1035	96.1	porB1b.l15.c4.ctg.1	1824	97.4	0	.	p	.	0	E210fs	FSHIFT	628	628	G	1153	1153	G	121	G	99	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	606	porB1b	1035	1035	96.1	porB1b.l15.c4.ctg.1	1824	97.4	1	SNP	p	G120K	0	.	.	358	360	GGT	883	885	GGT	114;115;114	G,T;G;T	100,1;101;100	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	606	porB1b	1035	1035	96.1	porB1b.l15.c4.ctg.1	1824	97.4	1	SNP	p	A121D	0	.	.	361	363	GCC	886	888	GCC	113;113;113	G;C;C	97;101;100	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	606	porB1b	1035	1035	96.1	porB1b.l15.c4.ctg.1	1824	97.4	1	SNP	p	A121N	0	.	.	361	363	GCC	886	888	GCC	113;113;113	G;C;C	97;101;100	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2082	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5310	117.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2198	2200	AAT	103;104;104	A;A;T	86;90;88	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	330	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1429	68.5	1	SNP	p	V57M	1	.	.	169	171	ATG	628	630	ATG	117;117;117	A;T;G	99;100;97	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
